Edition:
United States

Merus NV (MRUS.OQ)

MRUS.OQ on NASDAQ Stock Exchange Global Market

17.11USD
19 Apr 2018
Change (% chg)

-- (--)
Prev Close
$17.11
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,302
52-wk High
$23.50
52-wk Low
$13.33

Select another date:

Tue, Mar 20 2018

BRIEF-Merus And Vall d'Hebron Institute Of Oncology Announce Research Collaboration

* MERUS AND VALL D'HEBRON INSTITUTE OF ONCOLOGY ANNOUNCE RESEARCH COLLABORATION TO DEVELOP INNOVATIVE BISPECIFIC ANTIBODIES FOR THERAPEUTIC APPLICATIONS IN TREATMENT OF CANCER Source text for Eikon: Further company coverage:

BRIEF-Merus Says Ono Pharma Exercised Option For New Research And License Agreement

* MERUS ANNOUNCES ONO PHARMACEUTICALS EXERCISE OF ITS OPTION FOR NEW RESEARCH AND LICENSE AGREEMENT TO GENERATE BISPECIFIC ANTIBODY TARGETING AUTOIMMUNE DISEASES

BRIEF-Merus Announces $55.8 Mln Private Placement Offering

* MERUS ANNOUNCES $55.8 MILLION PRIVATE PLACEMENT OFFERING OF COMMON STOCK

BRIEF-Merus Provides Clinical Updates For Mcla-117 And Mcla-158 Programs

* MERUS PROVIDES CLINICAL UPDATES FOR MCLA-117 AND MCLA-158 PROGRAMS

Appeals court denies Regeneron bid to revive patent case against Merus

A federal appeals court on Tuesday refused to reconsider its ruling that a patent Regeneron Pharmaceuticals Inc asserted against rival Merus NV is unenforceable because it was obtained through deception.

BRIEF-Merus Nv Q3 Loss Per Share Eur 0.81

* MERUS ANNOUNCES THIRD QUARTER 2017 FINANCIAL RESULTS AND CLINICAL HIGHLIGHTS

Select another date: